Skip to main content

Your search for “Drug Discovery” returned 442 results

$1M Gift Speeds COVID-19 Testing and Tracking at UC San Diego

May 29, 2020

A $1 million gift from the John and Mary Tu Foundation is helping to increase the number of people tested for COVID-19, as well as develop new ways to track and treat the virus.

UC San Diego Cancer Researchers Receive NCI Outstanding Investigator Award

August 28, 2015

Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.

Napoleone Ferrara Awarded The Economist’s 2012 Innovation Award for Bioscience

November 16, 2012

Napoleone Ferrara, MD, PhD, the molecular biologist credited with helping decipher how tumors grow, and with development of new treatments for both cancer and age-related macular degeneration, has been named recipient of The Economist magazine’s 2012 Innovation Award for bioscience.

Cancer Drug Could Ease Cognitive Function for Some With Autism

July 25, 2024

An experimental cancer drug could ease cognition for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the Muotri Lab at the University of California San Diego — a discovery that could lead to therapies for patients with other neurologic conditions.

Simulations from Atom to Organ Reveal Novel Treatment Mechanisms for Heart Failure

August 19, 2024

A team of researchers from UC San Diego has developed the first multiscale computational model to simulate the therapeutic mechanisms of a drug candidate for heart failure from the atomic level to the organ system scale.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

May 4, 2020

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

Campus Leaders Describe Plans to “Flash Forward from 50” in Research and Discovery

December 6, 2011

…50’ in Research and Discovery Photos by Erik Jepsen/UC San Diego Publications As the campus looks beyond last year’s 50th anniversary celebrations, university leaders are developing a new long-term vision for the decades ahead. The central idea behind that vision is a familiar one: “We will build on faculty collaboration…

UC San Diego oneAPI Center of Excellence to Bring High-performance Simulations to Amber

September 23, 2022

The University of California San Diego announces establishing a new oneAPI Center of Excellence at its San Diego Supercomputer Center. The oneAPI Center will focus on enabling high-performance molecular dynamics simulations in Amber—a biomolecular simulations software package used by thousands.

Researchers Develop New Tools to Optimize CHO Cell Lines for Making Biologic Drugs

April 13, 2017

…metabolic models, to optimize CHO cell production of biologic drugs in the hope of driving down their costs.

Scott M. Lippman, MD, Named New Director of UC San Diego Moores Cancer Center

April 13, 2012

Scott M. Lippman, MD, chair of Thoracic/Head and Neck Medical Oncology at The University of Texas (UT) MD Anderson Cancer Center, has accepted the position of director of Moores Cancer Center at the University of California, San Diego, beginning May 1, 2012.

Category navigation with Social links